期刊文献+

获得性顺铂耐药的大肠腺癌LS-174T细胞核中YB-1的活性改变及其对P-gp和PCNA转录表达的影响

Increased nuclear localization of transcription factor YB-1 and its subsequent influence on transcription of P-gp and PCNA in acquired cisplatin-resistant colon adenocarcinoma cell line
下载PDF
导出
摘要 目的:观察耐药细胞株LS-174T核中YB-1的活性改变及其对P-gp和PCNA转录表达水平的影响,探讨YB-1在肿瘤顺铂耐药机制中的作用。方法:采用顺铂药物浓度递增法、间歇性作用的体外诱导法建立人结肠癌的多重耐药细胞系LS-174T;用EMSA检测耐药肿瘤细胞核中转录因子YB-1活性的改变,半定量RT-PCR检测P-gp和PCNA mRNA表达水平的改变。结果:耐药细胞株核中YB-1的活性明显增加,且P-gp mRNA和PCNA mRNA的表达水平均较非耐药细胞株明显增高(P<0.01)。结论:顺铂耐药细胞株细胞核内YB-1活性增高促进了P-gp和PCNA转录表达水平,它们可能共同参与顺铂导致DNA损伤的修复,在肿瘤耐药机制中发挥重要作用。 Objective :To observe the level of YB-1 activity in the nuclei of acquired cisplatin-resistant colon ad cell line and its secondary effect on the transcription of P-gp and PCNA, and to elucidate the association between nuclear YB-1 and cisplatin resistance in human colon adenocarcinoma. Methods:A LS-174T cell line resistant to cisplatin was successfully established by exposing cells to increasing cisplatin concentrations ranging from 200 ng/ml to 2 000 ng/ml on an intermittent dosage schedule, Intranuclear YB-1 transcriptional activity was examined by EMSA analysis for both cisplatin sensitive and resistant human colon adenocarcinoma cell line. The alterations of P-gp and PCNA mRNA levels were measured by semi-quantitative RT-PCR. Results:EMSA analysis for nuclear extracts indicated that cisplatin-resistant cells showed much higher nuclear YB-1 activity than that of sensitive parental cells. Meanwhile, the transcriptional expression of P-gp and PCNA gene was also increased as well (P 〈 0. 01 ). Conclusion:The increased activity of YB-1 in the nuclei enhanced the P-gp and PCNA gene expression at transcriptional level. They might be involved in DNA repair in LS-174T cells and play an important role in the drug resistance mechanism.
出处 《临床肿瘤学杂志》 CAS 2007年第8期566-569,共4页 Chinese Clinical Oncology
基金 全军"十一五"课题项目(No.06MA089)
关键词 Y-Box结合蛋白1 人结肠癌 获得性顺铂耐药 Nuclear YB-1 Human colon carcinoma Acquired cisplatin resistance
  • 相关文献

参考文献10

  • 1Kohno K,Izumi H,Uchiumi T,et al.The pleiotropic functions of the Y-box-binding protein,YB-1[J].Bioessays,2003,25(7):691-698.
  • 2Ohga T,Uchiumi T,Makino Y,et al.Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene[J].J Biol Chem,1998,273(11):5997-6000.
  • 3丁磊,陈孝平,张志伟,王海,曹斌,王志辉,黎春蕾.人肿瘤坏死因子α联合溴隐亭对人肝癌裸鼠耐药模型耐药性逆转的研究[J].中华外科杂志,2005,43(19):1248-1253. 被引量:2
  • 4童强松,曾甫清,齐义鹏,朱朝晖,赵军,鲁功成.增殖细胞核抗原反义真核表达载体的构建及其在膀胱癌EJ细胞中的表达[J].中华实验外科杂志,2001,18(6):559-561. 被引量:4
  • 5Ise T,Nagatani G,Imamura T,et al.Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen[J].Cancer Res,1999,59(2):342-346.
  • 6Izumi H,Imamura T,Nagatani G,et al.Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'→5' exonuclease activity[J].Nucleic Acids Res,2001,29(5):1200-1207.
  • 7Gaudreault I,Guay D,Lebel M.YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications,exhibits endonucleolytic activities and binds several DNA repair proteins[J].Nucleic Acids Res,2004,32(1):316-327.
  • 8Koike K,Uchiumi T,Ohga T,et al.Nuclear translocation of the Y-box binding protein by ultraviolet irradiation[J].FEBS Lett,1997,417(3):390-394.
  • 9Galani E,Sgouros J,Petropoulou C,et al.Correlation of MDR-1,nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients[J].Anticancer Res,2002,22(4):2275-2280.
  • 10Grude P,Conti F,Mennecier D,et al.MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis[J].Cancer Lett,2002,186(1):107-113.

二级参考文献10

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部